Evidence map›Paper›PMID 28839202›Full record

ArticleScientific reports2017

Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation.

Dan Wang, Chendong Yang, Zhuien Wang, Yi Yang, Defang Li, Xiaojie Ding, Wenjuan Xu, Qiusheng Zheng

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. A Systematic Review of Antiaging Effects of 23 Traditional Chinese Medicines.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  11. Article
  12. YYFZBJS ameliorates colorectal cancer progression in ApcCell communication and signaling : CCS · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Dan WangBinzhou Medical University, Yantai, 264003, China.
Chendong YangYantai Hospital of Traditional Chinese Medicine, Yantai, 264003, China.
Zhuien WangBinzhou Medical University, Yantai, 264003, China.
Yi YangBinzhou Medical University, Yantai, 264003, China.
Defang LiBinzhou Medical University, Yantai, 264003, China.
Xiaojie DingBinzhou Medical University, Yantai, 264003, China.
Wenjuan XuBinzhou Medical University, Yantai, 264003, China. xwjycd@126.com.
Qiusheng ZhengBinzhou Medical University, Yantai, 264003, China. zqsyt@sohu.com.
Binzhou University · CNBinzhou Medical University · CNYantaishan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune system plays a critical role in exerts effects in the growth and progression of hepatocellular carcinoma (HCC), which needs interacting approaches for effective therapy. In this study, we have found that the Norcantharidin (NCTD) + Coix lacryma-jobi seed oil (CLSO) combination exhibited more potent antitumor effects in an terms of cytotoxicity and apoptotic induction in human HepG2 and HepG2/ADM cells than NCTD or CLSO alone. In vivo, administration of NCTD+CLSO combinations significantly suppressed the formation of tumor in Hepal-1 hepatoma-bearing mice. Furthermore, we found that the in vitro co-cultures of HepG2 or HepG2/ADM cells with PBMCs from healthy donors led to an increase in the number of CD4

Indexed as

AnimalsAntineoplastic AgentsApoptosisBiomarkersBridged Bicyclo Compounds, HeterocyclicCarcinoma, HepatocellularCell Cycle CheckpointsCell Line, TumorCell ProliferationCell SurvivalCoixDisease Models, AnimalDose-Response Relationship, DrugDrug SynergismHumansImmunophenotypingAntineoplastic AgentsBiomarkersBridged Bicyclo Compounds, HeterocyclicnorcantharidinPlant Oils

Identifiers

PMID28839202
PMCPMC5571147
OpenAlexW2747229058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.